Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
University of Minnesota · NCT04439370
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 35–70 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 160
- US sites recruiting
- 1
- Study start
- October 1, 2019
- Record last updated
- January 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a cross-sectional study in which the investigators will determine the impact of premature/early menopause on MSNA, BP and baroreflex sensitivity in younger (≤49 yr old) and older (≥50 yr old) women. Specifically, aim one will determine mechanisms driving autonomic dysregulation of BP in premature and early menopausal women and aim two will determine mechanisms driving autonomic dysregulation of BP in older menopausal women. The study design outlined below will permit testing of aim one and aim two.
Being studied: Microneurography to measure muscle sympathetic nerve activity (MSNA); Baroreflex sensitivity testing; Sympathoexcitatory Maneuvers; Blood tests
Conditions: Hypertension; Menopause, Premature; Menopause; Blood Pressure
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Aged 35-49 or 50-70 years of age who experienced premature (\<40) or early (≤45) menopause
- Premenopausal 35-49 years of age
- Typical-age menopause (i.e., after 45 years of age), who are between 50-70 years old
- Menopause will be confirmed by subject report of amenorrhea for 12 months and serum FSH of >30 mIU/mL
Exclusion Criteria
- Current nicotine/tobacco use within the past six months
- Are diabetic or asthmatic
- Have diagnosed significant carotid stenosis
- Have a history of significant autonomic dysfunction, heart disease, respiratory disease or a severe neurologic condition such as stroke or traumatic brain injury.
- Have existing metabolic or endocrine abnormities
- Take any heart/blood pressure medications that are determined to interfere with study outcomes
- IF the participant is premenopausal AND currently taking OC or other exogenous steroids that are determined to interfere with study outcomes
- Females who classify as having early or premature menopause AND are not willing to discontinue OC or MHT in order to complete the study
- Are pregnant or breastfeeding
Recruiting US locations
University of Minnesota
Minneapolis, MN 55455
Site contact: Manda Keller-Ross, PhD, DPT, PT · 612-625-3175 · kell0529@umn.edu
Study contacts (from the official record)
- Manda Keller-Ross, PhD, DPT, PT · 612-625-3175 · kell0529@umn.edu
Similar studies in Minnesota
All heart & blood pressure studies in Minnesota →- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Rochester, MN + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Rochester, MN + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
AliveCor
- Location
- Rochester, MN + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Minneapolis, MN + 64 other US sites
- Eligibility basics
- Ages 18+